ALBIX – US Trademark 79141004 of Albumedix Ltd

Trademark image

ALBIX (U.S. Trademark Serial Number 79141004) is a United States trademark of Albumedix Ltd. The goods and services include: Line 33, “in the field of development of medicines and pharmaceutical products” should be inserted after “cells” in class 42. Pharmaceutical products and substances; reagents * for pharmaceutical and medical use * ; diagnostic reagents * for medical use * ; proteins * for pharmaceutical and medical use * ; albumin * for pharmaceutical and medical use * ; recombinant albumin * for pharmaceutical and medical use * ; diagnostic imaging agents In the Statement, Page 1, lines 5 – 11, “Chemicals used in industry, science, agriculture, horticulture and forestry except herbicides, fungicides, parasiticides and insecticides; chemicals for use in medicines and in the preparation of pharmaceuticals, namely, excipients for the stabilisation of pharmaceuticals and vaccines; reagents, namely, medium ingredient for the growth of animal cell lines; diagnostic reagents for biochemical analysis; proteins, namely, proteins for industrial use; ” should be deleted, and, In the Statement, Page 1, lines 15-17, “; chemical substances for use in tissue culture, namely, cell growth media for growing animal cells, stem cells and cell therapy preparations” should be deleted, and, In the Statement, Page 1, line 19, after reagents, “for pharmaceutical and medical use” should be inserted, and, In the Statement, Page 1, line 20 after REAGENTS, “for medical use” should be inserted, and, In the Statement, Page 1, line 20, after PROTEINS, “for pharmaceutical and medical use” should be inserted, and, In the Statement, Page 1, line 20, after ALBUMIN, “for pharmaceutical and medical use” should be inserted, and, In the Statement, Page 1, line 20, after, RECOMBINANT ALBUMIN, “for pharmaceutical and medical use” should be inserted, and, In the Statement, Page 2, line 1, after ALL RELATING TO, “the use of albumin in” should be inserted.. The correspondent is Potter Clarkson LLP of The Belgrave Centre,.

This trademark was filed on October 09, 2013 as United States Trademark Application Serial Number 79141004. The trademark application was registered on September 23, 2014 as U.S. Trademark Registration 4607782.

Trademark PTO Status History

July 04, 2022 – TOTAL INVALIDATION PROCESSED BY THE IB

April 22, 2022 – TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

April 22, 2022 – INVALIDATION PROCESSED

December 09, 2021 – TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

April 23, 2021 – CHANGE OF NAME/ADDRESS REC’D FROM IB

April 09, 2021 – CANCELLED SECTION 71

January 23, 2020 – NEW REPRESENTATIVE AT IB RECEIVED

September 23, 2019 – COURTESY REMINDER – SEC. 71 (6-YR) E-MAILED

View full trademark status information at USPTO

Ownership History

Albumedix Ltd

Albumedix A/S

Novozymes Biopharma DK A/S

View documents on file at USPTO

File a Trademark or Get Help With Trademark Law

Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.